Production (Stage)
D
Femasys Inc. FEMY
$1.04 -$0.02-1.89% NASDAQ
Recommendation
Prev Close
$1.04
Volume
46,357
Avg Vol (90D)
363,447
Market Cap
$28.33M
Dividend & Yield
--
52-Week Range
$0.86 - $1.80
P/E (TTM)
--
EPS (TTM)
-$0.913
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Femasys Receives Nasdaq Delisting Notice for Low Market Value
5/23/2025 - TipRanks Financial Blog
Femasys (FEMY): Analyst Maintains Buy Rating, Lowers Price Target FEMY Stock News
5/13/2025 - GuruFocus
Femasys price target lowered by $4 at JonesResearch, here's why
5/13/2025 - The Fly
Femasys (NASDAQ:FEMY) and Alpha Tau Medical (NASDAQ:DRTS) Head-To-Head Analysis
5/11/2025 - Ticker Report
Femasys (FEMY) Target Price Lowered by 20% by HC Wainwright & Co. FEMY Stock News
5/9/2025 - GuruFocus
Femasys GAAP EPS of -$0.23
5/9/2025 - SeekingAlpha.com: All News
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
5/8/2025 - Zacks Investment Research
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
5/8/2025 - GuruFocus
Femasys Inc (FEMY) Q1 2025 Earnings: EPS of -$0.20 and Revenue of $1.14 Million Meet Estimates
5/8/2025 - GuruFocus
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate ...
5/8/2025 - GuruFocus
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
5/8/2025 - Globe Newswire
Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates
5/6/2025 - Zacks Investment Research
BioMarin Pharmaceutical (BMRN) Beats Q1 Earnings and Revenue Estimates
5/1/2025 - Zacks Investment Research
Femasys reports FY results
4/2/2025 - SeekingAlpha.com: All News
Femasys (NASDAQ:FEMY) Given Buy Rating at HC Wainwright
3/31/2025 - Ticker Report
Femasys Inc. (NASDAQ:FEMY) Short Interest Update
3/30/2025 - Ticker Report
Femasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be Optimistic
3/27/2025 - Stocktwits News Feed
Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates
3/27/2025 - Zacks Investment Research
Femasys Inc Reports Annual Revenue of $2.68 Million and EPS of -0.80, Meeting Analyst Estimates
3/27/2025 - GuruFocus
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update
3/27/2025 - GuruFocus
Femasys reports FY24 EPS (85c), consensus (81c)
3/27/2025 - The Fly
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update
3/27/2025 - Globe Newswire
HC Wainwright Boosts Femasys (NASDAQ:FEMY) Price Target to $15.00
3/20/2025 - Ticker Report
Femasys price target raised to $15 from $12 at H.C. Wainwright
3/19/2025 - TipRanks Financial Blog
Femasys price target raised by $3 at H.C. Wainwright, here's why
3/19/2025 - The Fly
Income Statement
Total Revenue (TTM)
$1.70M
EBITDA (TTM)
-$19.47M
EBIT (TTM)
-$19.78M
Net Income (TTM)
-$21.11M
Balance Sheet
Total Assets (Q)
$13.28M
Total Debt (Q)
$7.67M
Total Liabilities (Q)
$11.28M
Book Value Per Share (Q)
$0.0737
Cash Flow
Cash from Operations (TTM)
-$19.64M
Cash from Investing (TTM)
-$854.20K
Cash from Financing (TTM)
$6.48M
Net Change in Cash (TTM)
-$14.02M
Filings
Filing Date
Thursday, May 8, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
-2.72
7-Day Total Return
-2.80%
30-Day Total Return
-8.77%
60-Day Total Return
-33.76%
90-Day Total Return
-1.89%
Year to Date Total Return
-5.45%
1-Year Total Return
-18.75%
2-Year Total Return
38.67%
3-Year Total Return
-28.28%
5-Year Total Return
--
52-week Low
Aug 08, 2024 - $0.86
52-week High
Feb 21, 2025 - $1.80
Valuation
Market Cap
$28.33M - Nano Cap
Enterprise Value
$32.18M
Price/Sales (TTM)
15.41
Price/Book (Q)
14.11
Dividends and Shares
Shares Outstanding
25.15M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.femasys.com
Phone Number
770 500 3910
Address
3950 Johns Creek Court
Suwanee, GA 30024
Country
United States
Year Founded
2004
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an... more
NASDAQ 05/23/2025 4:00PM Eastern Quotes delayed